Having established that Evi1 was upregulated in vivo by BCR–ABL and NUP98–HOXA9, we analyzed a role for Evi1 as a direct driver in CML-BC. Here, HOXA9 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.